Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Bioinformatics and Biotechnology

Date Submitted: Jan 23, 2021
Date Accepted: Dec 11, 2021

The final, peer-reviewed published version of this preprint can be found here:

Convolutional Neural Network–Based Automatic Classification of Colorectal and Prostate Tumor Biopsies Using Multispectral Imagery: System Development Study

Peyreta R, AlSaeed D, Khelifi F, Alghreimil N, Al-Baity H, Bouridane A

Convolutional Neural Network–Based Automatic Classification of Colorectal and Prostate Tumor Biopsies Using Multispectral Imagery: System Development Study

JMIR Bioinform Biotech 2022;3(1):e27394

DOI: 10.2196/27394

PMCID: 11135179

Convolutional Neural Network based Automatic Classification of Colorectal and Prostate Tumour Biopsies using Multispectral Imagery

  • Remy Peyreta; 
  • Duaa AlSaeed; 
  • Fouad Khelifi; 
  • Nadia Alghreimil; 
  • Heyam Al-Baity; 
  • Ahmed Bouridane

ABSTRACT

Background:

Colorectal and prostate cancer are the most dominant kind of cancer in men recorded all over the world. To diagnose colorectal and prostate, a pathologist performs a histological analysis on needle biopsy samples. This manual process is time-consuming and error-prone. This results in a high intra- and inter-observer variability, which affects the reliability of the diagnosis.

Objective:

The primary objective of our study is to develop a computerized automatic system for diagnosis of colorectal and prostate tumors using images of biopsy samples in order to reduce the human analysis time and the diagnosis error rates.

Methods:

In this work, we propose a CNN model (based on VGG16 [3] ) for classification of colorectal and prostate tumors from multispectral images of biopsy samples. The key idea is based on removing the last block of convolutional layers and halved the number of lters per layer.

Results:

The results show excellent performances achieving an average test accuracy of 99.8 % and 99.5% for the prostate and colorectal datasets, respectively. It shows excellent performance compared to pre-trained CNNs and to other classification methods as it avoids the preprocessing phase while using a single CNN model for the whole classification task. Over-all, the proposed CNN architecture was globally the best performing system for classifying colorectal and prostate tumor images.

Conclusions:

A proposed CNN architecture was detailed and compared to previously trained network models used as feature extractors. These CNNs were also compared to other classification techniques. As opposed to pre-trained CNNs and other classification approaches, the proposed CNN gave excellent results. The computational complexity of the CNNs was also investigated, and it was shown that the proposed CNN is better at classifying images than pre-trained networks because it does not require preprocessing. Thus, the overall analysis was that the proposed CNN architecture was globally the best performing system for classifying colorectal and prostate tumour images.


 Citation

Please cite as:

Peyreta R, AlSaeed D, Khelifi F, Alghreimil N, Al-Baity H, Bouridane A

Convolutional Neural Network–Based Automatic Classification of Colorectal and Prostate Tumor Biopsies Using Multispectral Imagery: System Development Study

JMIR Bioinform Biotech 2022;3(1):e27394

DOI: 10.2196/27394

PMCID: 11135179

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.